Insiders · Profile

Mallon Mark

Chief Executive Officer at NEOGENOMICS · Chief Executive Officer at IRONWOOD PHARMACEUTICALS. Filing since 21 Feb 2020. CIK 0001763533

Company

Date

Role

Action

Amount

Of holding

6 Dec 2021

Chief Executive Officer

Bought

17,000

$520.71K

30.5%

26 Feb 2021

Chief Executive Officer

Sold, plan not stated

30,675

$279.45K

6.1%

11 May 2020

Chief Executive Officer

Sold, plan not stated

23,206

$240.18K

4.4%

24 Feb 2020

Chief Executive Officer

Sold, plan not stated

$11.25

0.0%

21 Feb 2020

Chief Executive Officer

Sold, plan not stated

7,983

$92.84K

2.6%

5 decisions on file.